UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000032875
Receipt No. R000037487
Scientific Title Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Date of disclosure of the study information 2018/07/01
Last modified on 2019/12/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Acronym Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Scientific Title Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Scientific Title:Acronym Feasibility study of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Region
Japan

Condition
Condition metastatic lung tumors from adenoid cystic carcinoma
Classification by specialty
Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the safety of radiotherapy using CyberKnife for metastatic lung tumors from adenoid cystic carcinoma
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Toxicity
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
12 years-old <=
Age-upper limit
95 years-old >=
Gender Male and Female
Key inclusion criteria 1) diagnosed as metastatic lung tumors from adenoid cystic carcinoma in clinical course
2) measurable tumors
3) a performance status of 0-2
Key exclusion criteria The presence of other primary cancers
Target sample size 5

Research contact person
Name of lead principal investigator
1st name Tsuneo
Middle name
Last name Shimizu
Organization Kanto Neurosurgical Hospital
Division name Cyber Center
Zip code 360-0804
Address 1120, Dai, Kumagaya, Saitama 360-0804 JAPAN
TEL 048-521-3133
Email kantou@ps.ksky.ne.jp

Public contact
Name of contact person
1st name Hiro
Middle name
Last name Sato
Organization Gunma University Graduate School of Medicine
Division name Department of Radiation Oncology
Zip code 371-8511
Address 3-39-22 Showa-machi, Maebashi, Gunma 371-8511 JAPAN
TEL 027-220-8383
Homepage URL
Email h-sato0808@hotmail.co.jp

Sponsor
Institute Kanto Neurosurgical Hospital
Institute
Department

Funding Source
Organization Kanto Neurosurgical Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kanto Neurosurgical Hospital
Address 1120, Dai, Kumagaya, Saitama 360-0804 JAPAN
Tel 048-521-3133
Email kantou@ps.ksky.ne.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 1
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2018 Year 06 Month 05 Day
Date of IRB
2018 Year 06 Month 05 Day
Anticipated trial start date
2018 Year 06 Month 07 Day
Last follow-up date
2019 Year 12 Month 25 Day
Date of closure to data entry
2019 Year 12 Month 25 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information 1) diagnosed as metastatic lung tumors from adenoid cystic carcinoma in clinical course
2) measurable tumors
3) a performance status of 0-2

Management information
Registered date
2018 Year 06 Month 05 Day
Last modified on
2019 Year 12 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037487

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.